On 27 March, 2017, Monika Duszyńska at the conference „Healthcare Provider 2017 - Key changes in the health care system” raised the issue of the hospital's responsibility for clinical effects of treatment in the context of treatment continuation and drug substitution (primarily biological drugs). Monika referred to patients' rights in terms of the choice of [...]

Our law firm has been recognized in the recent edition of Polityka Insight ranking of the Polish regulatory law firms, in the category of the pharmaceutical law. Polityka Insight ranking is the first ranking in Poland taking into account quality data; its results come from research data obtained from the companies from determined sectors and [...]